LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹307 Cr | ₹297 Cr | ₹263 Cr | ₹245 Cr | ₹182 Cr |
What is the latest Total Non-Current Assets ratio of LINCOLN PHARMACEUTICALS ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2026 | ₹307 Cr |
| Mar2025 | ₹297 Cr |
| Mar2024 | ₹263 Cr |
| Mar2023 | ₹245 Cr |
| Mar2022 | ₹182 Cr |
How is Total Non-Current Assets of LINCOLN PHARMACEUTICALS Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹307 Cr | 3.46 | |
| Mar2025 | ₹297 Cr | 13.16 | |
| Mar2024 | ₹263 Cr | 6.96 | |
| Mar2023 | ₹245 Cr | 35.21 | |
| Mar2022 | ₹182 Cr | - | |
Compare Total Non-Current Assets of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,042.2 Cr | 1.6% | -4.3% | -0.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹454,914.0 Cr | 3.9% | 7.8% | 13% | Stock Analytics | |
| DIVIS LABORATORIES | ₹300,380.0 Cr | 11.5% | 20.6% | 68% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,169.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,933.0 Cr | 1.1% | 11.8% | 14.9% | Stock Analytics | |
| CIPLA | ₹114,478.0 Cr | 1.1% | 7.9% | -6.3% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 1.6% |
-4.3% |
-0.4% |
| SENSEX | 5.9% |
13% |
-1.9% |
You may also like the below Video Courses